Guidant Corp.

Recent Events

News & Analysis

company and guidant corp. - All News and Analysis

• Mr. Frank Menzler Appointed as President and CEO of HepaLife

  - 2006-10-03

  Senior Executive with Worldwide Medical Device Development and Commercialization; Previously with Abiomed, Inc. and Guidant Corporation BOSTON -- HepaLife Technologies Inc. (OTCBB: HPLF) (FWB: HL1), today announced the appointment of Mr. Frank Menzler as its President, Chief Executive Officer, and a Director of the Company. Mr. Frank Menzler...

  Tags: Company, FINANCE, Government, Guidant Corp., HEALTHCARE, MARKETING, SEC

• Biocompatibles International plc - ABBOTT TO ACQUIRE GUIDANT VASCULAR BUSINESS.

  - 2006-01-10

  10th January 2006 BIOCOMPATIBLES INTERNATIONAL PLC ...

  Tags: Abbott Laboratories Inc., Boston Scientific Corp., Company, Guidant Corp.

• Guidant gets FDA warning letter on facility.

  - 2005-12-28

  M2 PRESSWIRE-28 December 2005-SessionsIR.com: Guidant gets FDA warning letter on facilityC1994-2005 M2 COMMUNICATIONS LTD RDATE:28122005 Stocks in the News: Guidant Corporation (NYSE: GDT), Repligen Corporation (NASDAQ: RGEN), CalbaTech Incorporated, Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV) For Corporate or Company...

  Tags: Company, FDA, Government, Guidant Corp., Nasdaq Stock Market Inc., stem-cell

• Guidant Publishes Responses to U.S. Food and Drug Administration Form 483 Observations; Transcript Now Available on Company Website

  - 2005-10-27

  INDIANAPOLIS -- Guidant Corporation (NYSE:GDT) announced today that the Company has published its responses to the Form 483 observations issued by the U.S. Food and Drug Administration FDA. Guidant's responses address specific observations and detail broader steps that the Company intends to take to further enhance its Quality System. In...

  Tags: Company, FDA, Guidant Corp., Web site

• Tiger Team Holds Unique Patent: TTMT, PRX, AMGN, GOOG, GDT.

  - 2004-11-24

  M2 PRESSWIRE-24 November 2004-InvestSource Inc.: Tiger Team Holds Unique Patent: TTMT, PRX, AMGN, GOOG, GDTC1994-2004 M2 COMMUNICATIONS LTD RDATE:11242004 Stocks in the News: Tiger Team Technologies Incorporated (OTC: TTMT), Par Pharmaceutical Companies Incorporated (NYSE: PRX), Amgen Incorporated (NASDAQ: AMGN), Google...

  Tags: Amgen Inc., Company, FINANCE, financial, Guidant Corp., Nasdaq Stock Market Inc., NYSE Euronext, patent, team

• Guidant Updates Investors on the Strength of the Company's Business; Company Raises Third Quarter 2002 Sales and Earnings Per Share Guidance

  - 2002-08-28

  Business Editors

  Tags: Company, earnings per share, Guidant Corp.

• Angiotech Pharmaceuticals: Paclitaxel-Coated Coronary Stents From Cook Incorporated Virtually Eliminate In Stent Restenosis

  - 2001-09-11

  Business Editors WASHINGTON--BUSINESS WIRE--Sept. 11, 2001 Angiotech Pharmaceuticals (Nasdaq:ANPI) (TSE:ANP) was notified today by Cook Incorporated that coronary stents coated with paclitaxel virtually eliminated in stent restenosis in patients who had undergone repeated interventional therapy to treat blockages in previously stented coronary arteries, a 21-patient pilot study released...

  Tags: Angiotech Pharmaceuticals Inc., Company, Guidant Corp.

• Guidant Corp [Gdt] - Brief Article

  - 2000-05-15

  According to CEO Ron Dullens, Guidant Corp. enjoys a 53% share of the coronary stent market. The news is a double-edged sword for a company that realizes 36% of its revenue from the sale of stents. Investors can view the impressive market share as a rousing positive for the company....

  Tags: company, Guidant Corp., revenue

• Guidant posts record sales quarter; earnings impacted by special charges

  - 1996-07-15

  INDIANAPOLIS--HealthWire--July 15, 1996--Guidant Corporation (NYSE and PSE: GDT) today announced second quarter net sales of $265.5 million, an 18 percent increase over second quarter 1995 and a record for the company. As announced on May 20, the company took non-recurring, non-cash accounting charges in the quarter totaling $95.7 million...

  Tags: company, Guidant Corp., sales